Staying with that, Dr. Halperin, in a May 19, 2020, news release from Dalhousie University, you noted that the intellectual property rights for that vaccine will “stay in Chinese hands”, but the National Research Council's involvement would help ensure that Canada gets its guaranteed domestic supply.
Precisely what conditions are in place to ensure that Canada will receive a sufficient domestic supply of the vaccine if it proves to be successful?